In light of the delay on employer penalties for not offering healthcare insurance, some federal officials are demanding the same delay be made for the individual mandate.
WASHINGTON — House Republican leaders on Tuesday seized on the Obama administration’s one-year delay of a mandate for larger employers to offer health insurance or face penalties, demanding the same postponement for the mandate on individual insurance purchases and promising a series of showdowns aimed at dividing Democrats from the White House.
After more than two years of voting repeatedly and unsuccessfully to repeal the health care law, Republicans believe they are getting traction thanks to what they see as the Obama administration’s self-inflicted wound over the employer mandate.
In light of the delay on employer penalties for not offering healthcare insurance, some federal officials are demanding the same delay be made for the individual mandate. The New York Times reports:
House leaders began devising strategies that would most likely start this month with multiple votes, the first to codify the one-year delay on the employer mandate, then another to demand a delay on the individual mandate. They calculate that Democrats would first vote to back the administration’s decision, and would then have a hard time opposing the second measure. Some Republicans raised the possibility that a provision to repeal the individual mandate could be attached this fall to legislation raising the government’s statutory borrowing limit.
Read the full story here: http://nyti.ms/14GYJjj
Health Equity and Access Weekly Roundup: December 9, 2023
December 9th 2023The Center on Health Equity and Access provides information on the latest news, research discoveries, and initiatives dedicated to addressing healthcare disparities and improving overall access to high-quality care.
Read More
New TROPiCS-02 Data Back Sacituzumab Govitecan for Older Patients With Breast Cancer
December 9th 2023This phase 3 study investigated sacituzumab govitecan, a Trop-2–directed antibody-drug conjugate, vs treatment of physician’s choice in pretreated patients who have endocrine-resistant hormone receptor–positive/HER2-negative breast cancer, the most common form of breast cancer.
Read More
California Aims for Equity by Redefining Cancer Care
December 8th 2023Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Read More